A Dominant Negative Antisense Approach Targeting β-Catenin
Page 1 of 1
A Dominant Negative Antisense Approach Targeting β-Catenin
Jon Moulton Fri Mar 16, 2018 2:14 pm
Vonbrüll M, Riegel E, Halter C, Aigner M, Bock H, Werner B, Lindhorst T, Czerny T. A Dominant Negative Antisense Approach Targeting β-Catenin. Mol Biotechnol. 2018 Mar 9. doi: 10.1007/s12033-018-0058-7. [Epub ahead of print]
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 62
Location : Philomath, Oregon, USA -
Similar topics» A k-mer based transcriptomics approach for antisense drug discovery targeting the Ewing's family of tumors
» Antisense targeting of 3'end elements involved in DUX4 mRNA processing is an efficient therapeutic strategy for Facioscapulohumeral Dystrophy: a new gene silencing approach
» Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast Cancer
» Antisense modulation of RNA processing as a therapeutic approach in cancer therapy
» Bruton's tyrosine kinase revealed as a negative regulator of Wnt-beta-catenin signaling
» Antisense targeting of 3'end elements involved in DUX4 mRNA processing is an efficient therapeutic strategy for Facioscapulohumeral Dystrophy: a new gene silencing approach
» Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast Cancer
» Antisense modulation of RNA processing as a therapeutic approach in cancer therapy
» Bruton's tyrosine kinase revealed as a negative regulator of Wnt-beta-catenin signaling
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum